More than three-quarters of adults in the UK have now received their first dose of the COVID-19 vaccine.
Health Secretary Matt Hancock confirmed the milestone had been reached by midnight Tuesday in a speech in which he praised the role of the NHS, scientists, the UK’s drug regulator MHRA and the vaccines workforce. coronavirus Vaccination rollout.
Between 8 December and 1 June more than 65.6 million vaccines have now been administered across the UK, with over 39.5 million first doses – 75.2% of adults – and over 26 million second doses – 49.5% of adults.
Mr Hancock also announced that the government is in commercial talks with AstraZeneca to purchase a vaccine that works against the South Africa version (beta version), which was found to be more permeable.
another 4,330 daily COVID-19 Cases were reported in the UK soon after Mr Hancock disclosed the vaccine update – the highest figure since 1 April when there were 4,479.
And a day after zero deaths were announced, 12 other coronavirus-related deaths were reported within 28 days of testing positive.
Speaking at the University of Oxford, where the AstraZeneca vaccine was developed, Mr Hancock said his first meeting about the vaccine was in January 2020, when the genomic sequence of the virus was traced and said the vaccine could never be developed. Also cannot be developed in the form of jab. A human coronavirus had never been created before.
“Who would have thought that just 11 months later we would be able to deploy the first clinically approved coronavirus vaccine?” he said.
“I believe the UK vaccination success story was not an accident, it is a result of the actions we have taken, the decisions we have made before.”
Mr Hancock also revealed that last March he flew to Edinburgh, Belfast and Cardiff to hold a vaccine rollout “as a consortium” to speak face-to-face with health ministers from the devolved governments – he All that said was necessary to develop vaccines and into people’s arms.
Western countries have faced criticism for buying the vaccine, which Mr Hancock acknowledged, saying: “To date I can confirm that more than half a billion doses of the AstraZeneca vaccine have now been released for supply globally.” in most low- and middle-income countries.”
He said that Pfizer will also deliver its vaccine to low-income countries at a cost.
Mr Hancock’s remarks came amid ongoing debate over whether the final phase of opening restrictions in England could go ahead later this month due to concerns over the spread of the Indian version.
The health secretary said there is “nothing in the data yet to say we are definitely off track” to move into the fourth phase of the roadmap on June 21, adding that “it is too early to make a decision”. .
he echoed Boris Johnson’s commentThe Prime Minister also said that there was a need to “wait a little more” before taking a firm decision.
Several scientists have called for an easing of lockdowns, including Dr David Nabarro, the World Health Organization’s special envoy on COVID-19, who told Sky News that despite low infection levels, restrictions in the UK should be opened too early. Another situation may arise from this. Spike” in transition.
Disclaimer: The opinions expressed within this article are the personal opinions of the author. The facts and opinions appearing in the article do not reflect the views of knews.uk and knews.uk does not assume any responsibility or liability for the same.